Dr. Lal PathLabs Limited (LALPATHLAB.BO)
INR 2708.8
(-2.25%)
INR 2708.8
(-2.25%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 4.76 Billion INR | 33.74% |
| 2022 | 3.48 Billion INR | -24.62% |
| 2021 | 4.61 Billion INR | 26.5% |
| 2020 | 3.65 Billion INR | 32.23% |
| 2019 | 2.76 Billion INR | 6.2% |
| 2018 | 2.6 Billion INR | 11.31% |
| 2017 | 2.33 Billion INR | 10.11% |
| 2016 | 2.12 Billion INR | 16.91% |
| 2015 | 1.81 Billion INR | 29.73% |
| 2014 | 1.39 Billion INR | 15.47% |
| 2013 | 1.21 Billion INR | 49.02% |
| 2012 | 812.89 Million INR | 16.38% |
| 2011 | 698.45 Million INR | 50.64% |
| 2010 | 463.65 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 1.35 Billion INR | 25.16% |
| 2024 Q2 | 1.67 Billion INR | 23.58% |
| 2023 FY | 4.65 Billion INR | 33.74% |
| 2023 Q3 | 1.04 Billion INR | -26.29% |
| 2023 Q2 | 1.41 Billion INR | 27.72% |
| 2023 Q1 | 1.11 Billion INR | 42.44% |
| 2023 Q4 | 1.08 Billion INR | 3.35% |
| 2022 Q2 | 1.05 Billion INR | 28.68% |
| 2022 Q4 | 780 Million INR | 3.86% |
| 2022 FY | 3.48 Billion INR | -24.62% |
| 2022 Q3 | 751 Million INR | -28.48% |
| 2022 Q1 | 816 Million INR | -2.16% |
| 2021 Q1 | 1.69 Billion INR | 47.38% |
| 2021 FY | 4.61 Billion INR | 26.5% |
| 2021 Q4 | 834 Million INR | 6.24% |
| 2021 Q2 | 1.21 Billion INR | -28.74% |
| 2021 Q3 | 785 Million INR | -35.12% |
| 2020 Q3 | 1.32 Billion INR | 10.12% |
| 2020 Q1 | 418 Million INR | -15.24% |
| 2020 Q2 | 1.2 Billion INR | 188.52% |
| 2020 Q4 | 1.15 Billion INR | -13.24% |
| 2020 FY | 3.65 Billion INR | 32.23% |
| 2019 Q4 | 493.15 Million INR | -36.2% |
| 2019 Q3 | 773 Million INR | -27.08% |
| 2019 Q2 | 1.06 Billion INR | 13.73% |
| 2019 FY | 2.76 Billion INR | 6.2% |
| 2019 Q1 | 932 Million INR | 34.51% |
| 2018 Q4 | 692.87 Million INR | 1.59% |
| 2018 Q2 | 883 Million INR | 16.8% |
| 2018 Q1 | 756 Million INR | 21.54% |
| 2018 FY | 2.6 Billion INR | 11.31% |
| 2018 Q3 | 682 Million INR | -22.76% |
| 2017 Q2 | 781 Million INR | 18.15% |
| 2017 Q4 | 622 Million INR | 11.67% |
| 2017 Q1 | 661 Million INR | 34.9% |
| 2017 FY | 2.33 Billion INR | 10.11% |
| 2017 Q3 | 557 Million INR | -28.68% |
| 2016 Q4 | 490 Million INR | 3.16% |
| 2016 FY | 2.12 Billion INR | 16.91% |
| 2016 Q2 | 804 Million INR | 32.67% |
| 2016 Q1 | 606 Million INR | 14.23% |
| 2016 Q3 | 475 Million INR | -40.92% |
| 2015 Q1 | 468.6 Million INR | 17.28% |
| 2015 Q3 | 670.5 Million INR | 95.71% |
| 2015 Q4 | 530.5 Million INR | -20.88% |
| 2015 FY | 1.81 Billion INR | 29.73% |
| 2015 Q2 | 342.6 Million INR | -26.89% |
| 2014 FY | 1.39 Billion INR | 15.47% |
| 2014 Q4 | 399.57 Million INR | 16.94% |
| 2014 Q3 | 341.7 Million INR | 0.0% |
| 2013 FY | 1.21 Billion INR | 49.02% |
| 2012 FY | 812.89 Million INR | 16.38% |
| 2011 FY | 698.45 Million INR | 50.64% |
| 2010 FY | 463.65 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Krsnaa Diagnostics Limited | 696.99 Million INR | -583.327% |
| Metropolis Healthcare Limited | 2.05 Billion INR | -131.721% |
| Thyrocare Technologies Limited | 917 Million INR | -419.381% |
| Vijaya Diagnostic Centre Limited | 3.62 Billion INR | -31.258% |
| Vimta Labs Limited | 536.04 Million INR | -788.484% |